{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:10:20Z","timestamp":1775459420100,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11657-018-0439-3","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T13:30:43Z","timestamp":1521639043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women"],"prefix":"10.1007","volume":"13","author":[{"given":"Akeem A.","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurille Tepie","family":"Feudjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Sprafka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhila","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"439_CR1","unstructured":"American Academy of Orthopaedic Surgeons. Osteoporosis\/Bone Health in Adults as a National Public Health Priority. Position Statement. \n                    http:\/\/www.aaos.org\/about\/papers\/position\/1113.asp\n                    \n                  . Accessed 3 April, 2017"},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4065\/81.5.662","volume":"81","author":"KF Mauck","year":"2006","unstructured":"Mauck KF, Clarke BL (2006) Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc 81:662\u2013672","journal-title":"Mayo Clin Proc"},{"key":"439_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1524-4733.2006.00161.x","volume":"10","author":"MD Rousculp","year":"2007","unstructured":"Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES (2007) Economic burden of osteoporosis-related fractures in Medicaid. Value Health 10:144\u2013152","journal-title":"Value Health"},{"key":"439_CR4","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jgs.12507","volume":"61","author":"SK Liu","year":"2013","unstructured":"Liu SK, Munson JC, Bell JE, Zaha RL, Mecchella JN, Tosteson ANA, Morden NE (2013) Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc 61:1855\u20131862","journal-title":"J Am Geriatr Soc"},{"key":"439_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/gerona\/glt105","volume":"69","author":"GS Tajeu","year":"2014","unstructured":"Tajeu GS, Delzell E, Smith W et al (2014) Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci 69:346\u2013353","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2 Suppl","key":"439_CR6","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.amjmed.2008.12.003","volume":"122","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP (2009) Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am J Med 122(2 Suppl):S14\u2013S21","journal-title":"Am J Med"},{"key":"439_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"439_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"439_CR9","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mellstr\u00f6m D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J, Sawicki AZ, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"439_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/0003-4819-148-9-200805060-00003","volume":"148","author":"SM Cadarette","year":"2008","unstructured":"Cadarette SM, Katz JN, Brookhart MA, Sturmer T, Stedman MR, Solomon DH (2008) Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med 148:637\u2013646","journal-title":"Ann Intern Med"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1210\/jc.2013-1877","volume":"98","author":"TC Lin","year":"2013","unstructured":"Lin TC, Yang CY, Yang YH, Lin SJ (2013) Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women. J Clin Endocrinol Metab 98:4717\u20134726","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR12","first-page":"302","volume":"33","author":"H Yun","year":"2015","unstructured":"Yun H, Delzell E, Saag KG, Kilgore ML, Morrisey MA, Muntner P, Matthews R, Guo L, Wright N, Smith W, Col\u00f3n-Emeric C, O'Connor CM, Lyles KW, Curtis JR (2015) Fractures and mortality in relation to different osteoporosis treatments. Clin Exp Rheumatol 33:302\u2013309","journal-title":"Clin Exp Rheumatol"},{"key":"439_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00198-009-1046-3","volume":"21","author":"A Abelson","year":"2010","unstructured":"Abelson A, Ringe JD, Gold DT, Lange JL, Thomas T (2010) Longitudinal change in clinical fracture incidence after initiation of bisphosphonates. Osteoporos Int 21:1021\u20131029","journal-title":"Osteoporos Int"},{"key":"439_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","volume":"45","author":"WA Ray","year":"1992","unstructured":"Ray WA, Griffin MR, Fought RL, Adams ML (1992) Identification of fractures from computerized Medicare files. J Clin Epidemiol 45:703\u2013714","journal-title":"J Clin Epidemiol"},{"key":"439_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MLR.0b013e3181808c05","volume":"47","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG (2009) Identification and validation of vertebral compression fractures using administrative claims data. Med Care 47:69\u201372","journal-title":"Med Care"},{"key":"439_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jbmr.2011","volume":"29","author":"D Prieto-Alhambra","year":"2014","unstructured":"Prieto-Alhambra D, Pag\u00e8s-Castell\u00e0 A, Wallace G, Javaid MK, Judge A, Nogu\u00e9s X, Arden NK, Cooper C, Diez-Perez A (2014) Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study. J Bone Miner Res 29:268\u2013274","journal-title":"J Bone Miner Res"},{"key":"439_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-010-1300-8","volume":"22","author":"AJ Taylor","year":"2011","unstructured":"Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E (2011) Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int 22:1263\u20131274","journal-title":"Osteoporos Int"},{"key":"439_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2474-12-209","volume":"12","author":"RB Hopkins","year":"2011","unstructured":"Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L (2011) The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord 12:209","journal-title":"BMC Musculoskelet Disord"},{"key":"439_CR19","first-page":"1871","volume":"97","author":"MH Murad","year":"2012","unstructured":"Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, Abu Elnour NO, Erwin PJ, Hazem A, Puhan MA, Li T, Montori VM (2012) Clinical review. Comp Eff Drug Treat Prev Fragility Fractures 97:1871\u20131880","journal-title":"Comp Eff Drug Treat Prev Fragility Fractures"},{"key":"439_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","volume":"24","author":"N Freemantle","year":"2013","unstructured":"Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C (2013) Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int 24:209\u2013217","journal-title":"Osteoporos Int"},{"key":"439_CR21","first-page":"658","volume":"17","author":"A Migliore","year":"2013","unstructured":"Migliore A, Broccoli S, Massafra U, Cassol M, Frediani B (2013) Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis. Eur Rev Med Pharmacol Sci 17:658\u2013667","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"439_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.7326\/M14-0317","volume":"161","author":"CJ Crandall","year":"2014","unstructured":"Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures. Ann Intern Med 161:711\u2013723","journal-title":"Ann Intern Med"},{"key":"439_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00774-010-0249-1","volume":"29","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Nakamura T, Hagino H, Fujiwara S, Lange JL, Watts NB (2011) Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. J Bone Miner Metab 29:561\u2013570","journal-title":"J Bone Miner Metab"},{"key":"439_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00198-012-2060-4","volume":"24","author":"T Thomas","year":"2013","unstructured":"Thomas T, Horlait S, Ringe JD, Abelson A, Gold DT, Atlan P, Lange JL (2013) Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice. Osteoporos Int 24:263\u2013269","journal-title":"Osteoporos Int"},{"issue":"3","key":"439_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11914-010-0023-2","volume":"8","author":"TA Geel van","year":"2010","unstructured":"van Geel TA, Huntjens KM, van den Bergh JP, Dinant GJ, Geusens PP (2010) Timing of subsequent fractures after an initial fracture. Curr Osteoporos Rep 8(3):118\u2013122","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"439_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00198-003-1514-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Od\u00e9n A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, J\u00f6nsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175\u2013179","journal-title":"Osteoporos Int"},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/pds.3680","volume":"23","author":"V Hoffman","year":"2014","unstructured":"Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C (2014) Development and evaluation of an algorithm to identify users of Prolia(\u00ae) during the early postmarketing period using health insurance claims data. Pharmacoepidemiol Drug Saf 23:993\u2013998","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"439_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7326\/0003-4819-141-5-200409070-00100","volume":"141","author":"RB Doherty","year":"2004","unstructured":"Doherty RB (2004) Assessing the new Medicare prescription drug law. Ann Intern Med 141(5):391\u2013395","journal-title":"Ann Intern Med"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-018-0439-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:43:15Z","timestamp":1553128995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-018-0439-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s11657-018-0439-3","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"14 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We applied to and received approval from the Human Subjects Research Committee of the Hennepin County Medical Center\/Hennepin Healthcare Systems Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AAY, MFT, JMS, and AB are employees and stockholders of Amgen Inc. SRC has received consulting fees from Amgen Inc. NBW has received consulting fees from Abbvie, Amgen, and Radius and is a member of the Speakers Bureau for Amgen, Radius and Shire. JZ and HG have no disclosures. CC has received consulting fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Medtronic, Merck, Nestle, Novartis, Pfizer, Roche, Servier, Shire, Takeda, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"33"}}